Health stocks Eli Lilly (LLY), United Health Group (UNH), and Merck (MRK) have recently seen positive developments, including drug approvals and strong earnings. These gains have boosted their stock prices, with LLY up over 8% YTD, UNH up 25.8% YTD, and MRK up 19.9% YTD. Investors can gain diversified exposure to these companies through healthcare ETFs like VanEck Pharmaceutical ETF (PPH), Vanguard Health Care ETF (VHT), and State Street Health Care Select Sector SPDR ETF (XLV), which have all delivered solid returns around 21-27% over the past year. These ETFs offer a way to benefit from healthcare innovation and strong sector performance amid broader market shifts.
Nxera Pharma announced a net profit of JPY 1,591 million (US$10.1 million) for Q2 2026, reversing a prior loss due to multiple milestone payments from partners like Neurocrine, AbbVie, and Lilly. The company progressed regulatory approvals and commer...
Eli Lilly and Novo Nordisk both beat Q2 estimates and raised their full-year outlooks, but investors favored Lilly, boosting its shares while punishing Novo. Lilly leads the obesity drug market with a 60.9% U.S. share, driven by strong sales of Mounj...
Eli Lilly reported strong Q2 results with robust revenue growth led by key drugs Mounjaro and Zepbound. The company raised its 2026 revenue guidance to $85–87 billion, supported by volume gains despite price declines, and expects continued margin exp...
Eli Lilly reported a 48% year-on-year revenue increase to $22.97 billion, driven by strong sales of GLP-1 drugs Mounjaro and Zepbound, which make up about 65% of total revenue. The company raised its 2026 revenue guidance to $85 billion–$87 billion, ...
The Dow Jones surged 650 points to a new high of 54,740, and the S&P 500 also reached an all-time high, rising 0.7% to 7,790. However, tech stocks showed weakness with the Nasdaq up only 0.35%, dragged down by a 10% plunge in SpaceX shares after its ...
